Ohlmeier S - Search Results

1

Peroxiredoxin II expression and its association with oxidative stress and cell proliferation in human idiopathic pulmonary fibrosis.

Vuorinen K, Ohlmeier S, Leppäranta O, Salmenkivi K, Myllärniemi M, Kinnula VL. Vuorinen K, et al. Among authors: ohlmeier s. J Histochem Cytochem. 2008 Oct;56(10):951-9. doi: 10.1369/jhc.2008.951806. Epub 2008 Jul 7. J Histochem Cytochem. 2008. PMID: 18606608 Free PMC article.

2

Hemoglobin α and β are ubiquitous in the human lung, decline in idiopathic pulmonary fibrosis but not in COPD.

Ishikawa N, Ohlmeier S, Salmenkivi K, Myllärniemi M, Rahman I, Mazur W, Kinnula VL. Ishikawa N, et al. Among authors: ohlmeier s. Respir Res. 2010 Sep 13;11(1):123. doi: 10.1186/1465-9921-11-123. Respir Res. 2010. PMID: 20836851 Free PMC article.

3

Does the oxidative stress in chronic obstructive pulmonary disease cause thioredoxin/peroxiredoxin oxidation?

Lehtonen ST, Ohlmeier S, Kaarteenaho-Wiik R, Harju T, Pääkkö P, Soini Y, Kinnula VL. Lehtonen ST, et al. Among authors: ohlmeier s. Antioxid Redox Signal. 2008 Apr;10(4):813-9. doi: 10.1089/ars.2007.1952. Antioxid Redox Signal. 2008. PMID: 18179358

4

Proteomic approaches for studying human parenchymal lung diseases.

Kinnula VL, Ishikawa N, Bergmann U, Ohlmeier S. Kinnula VL, et al. Among authors: ohlmeier s. Expert Rev Proteomics. 2009 Dec;6(6):619-29. doi: 10.1586/epr.09.80. Expert Rev Proteomics. 2009. PMID: 19929608

5

Proteomic studies on receptor for advanced glycation end product variants in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease.

Ohlmeier S, Mazur W, Salmenkivi K, Myllärniemi M, Bergmann U, Kinnula VL. Ohlmeier S, et al. Proteomics Clin Appl. 2010 Jan;4(1):97-105. doi: 10.1002/prca.200900128. Epub 2010 Jan 7. Proteomics Clin Appl. 2010. PMID: 21137019

6

Distribution and levels of alpha-1-antitrypsin in the lung and plasma in smokers and chronic obstructive pulmonary disease.

Linja-aho A, Mazur W, Toljamo T, Nieminen P, Ohlmeier S, Rönty M, Kinnula VL. Linja-aho A, et al. Among authors: ohlmeier s. APMIS. 2013 Jan;121(1):11-21. doi: 10.1111/j.1600-0463.2012.02936.x. Epub 2012 Jun 28. APMIS. 2013. PMID: 23030783

7

Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease.

Ohlmeier S, Vuolanto M, Toljamo T, Vuopala K, Salmenkivi K, Myllärniemi M, Kinnula VL. Ohlmeier S, et al. J Proteome Res. 2008 Dec;7(12):5125-32. doi: 10.1021/pr800423x. J Proteome Res. 2008. PMID: 19367700

8

Sputum proteomics identifies elevated PIGR levels in smokers and mild-to-moderate COPD.

Ohlmeier S, Mazur W, Linja-Aho A, Louhelainen N, Rönty M, Toljamo T, Bergmann U, Kinnula VL. Ohlmeier S, et al. J Proteome Res. 2012 Feb 3;11(2):599-608. doi: 10.1021/pr2006395. Epub 2011 Nov 18. J Proteome Res. 2012. PMID: 22053820

9

Elevation of surfactant protein A in plasma and sputum in cigarette smokers.

Mazur W, Toljamo T, Ohlmeier S, Vuopala K, Nieminen P, Kobayashi H, Kinnula VL. Mazur W, et al. Among authors: ohlmeier s. Eur Respir J. 2011 Aug;38(2):277-84. doi: 10.1183/09031936.00110510. Epub 2011 Jan 27. Eur Respir J. 2011. PMID: 21273386 Free article.

10

Characterization of chronic subdural hematoma fluid proteome.

Heula AL, Ohlmeier S, Sajanti J, Majamaa K. Heula AL, et al. Among authors: ohlmeier s. Neurosurgery. 2013 Aug;73(2):317-31. doi: 10.1227/01.neu.0000430323.24623.de. Neurosurgery. 2013. PMID: 23632762

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters